Integration of miRNA’s theranostic potential with nanotechnology: Promises and challenges for Parkinson’s disease therapeutics

Inter and intracellular mitochondrial transfer: Future of mitochondrial transplant therapy in Parkinson’s disease

(2023) Rachit Jain et al.   BIOMEDICINE & PHARMACOTHERAPY

Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients

(2022) Elisa Zago et al.   Scientific Reports

Glutathione targeted tragacanthic acid-chitosan as a non-viral vector for brain delivery of miRNA-219a-5P: An in vitro/in vivo study

(2022) Nahal Shamaeizadeh et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

The Role of MicroRNAs in Proteostasis Decline and Protein Aggregation during Brain and Skeletal Muscle Aging

(2022) Stephany Francisco et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Mitochondria targeting drugs for neurodegenerative diseases—Design, mechanism and application

(2022) Jiajia Xu et al.   Acta Pharmaceutica Sinica B

NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's disease

(2022) Mayuri Khot et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics

(2022) Amrita Kulkarni et al.   AGEING RESEARCH REVIEWS

Exosomes derived from miR-188-3p -modified adipose-derived mesenchymal stem cells protect Parkinson’s disease

(2021) Qiang Li et al.   Molecular Therapy-Nucleic Acids

miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors

(2021) Florian Huemer et al.   Pharmaceuticals

Novel targeted therapies for Parkinson’s disease

(2021) Theodora Ntetsika et al.   MOLECULAR MEDICINE

Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points

(2021) Lucía Pinilla et al.   RNA Biology

The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders

(2021) Ebenezeri Erasto Ngowi et al.   Frontiers in Bioengineering and Biotechnology

Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson's disease: The therapeutic role of Nrf2 activators

(2021) Saravanan Jayaram et al.   NEUROCHEMISTRY INTERNATIONAL

MicroRNA Dysregulation in Parkinson’s Disease: A Narrative Review

(2021) Yong Hui Nies et al.   Frontiers in Neuroscience

Mitochondrial quality control: Epigenetic signatures and therapeutic strategies

(2021) Tanuja Ambekar et al.   NEUROCHEMISTRY INTERNATIONAL

Differential expression of gut miRNAs in idiopathic Parkinson's disease

(2021) Anna Kurz et al.   PARKINSONISM & RELATED DISORDERS

The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?

(2021) Adina N. MacMahon Copas et al.   Frontiers in Neurology

Nanotechnology-based drug delivery for central nervous system disorders

(2021) Thuy Trang Nguyen et al.   BIOMEDICINE & PHARMACOTHERAPY

Glia: A major player in glutamate–GABA dysregulation‐mediated neurodegeneration

(2021) Anika Sood et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study

(2021) Ida Manna et al.   PARKINSONISM & RELATED DISORDERS

Polydopamine nanoparticles attenuate retina ganglion cell degeneration and restore visual function after optic nerve injury

(2021) Xiaotong Lou et al.   JOURNAL OF NANOBIOTECHNOLOGY

Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases

(2020) Kyriacos Felekkis et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Diagnosis and Treatment of Parkinson Disease

(2020) Melissa J. Armstrong et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Modified level of miR‐376a is associated with Parkinson's disease

(2020) Masoud Baghi et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine

(2020) Alexandre Iarkov et al.   Frontiers in Aging Neuroscience

MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders

(2020) Dong Han et al.   Frontiers in Pharmacology

Nose-to-Brain Delivery

(2020) Paolo Giunchedi et al.   Pharmaceutics

Challenges identifying efficacious miRNA therapeutics for cancer

(2020) Meirav Segal et al.   Expert Opinion on Drug Discovery

MiR‐29c‐3p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson's disease

(2020) Ruili Wang et al.   GENES TO CELLS

Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma

(2020) Nilmary Grafals-Ruiz et al.   International Journal of Nanomedicine

Coordinated action of miR-146a and Parkin gene regulate Rotenone-induced neurodegeneration

(2020) Abhishek Jauhari et al.   TOXICOLOGICAL SCIENCES

Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson’s Disease

(2020) Deqiang Han et al.   Frontiers in Cellular Neuroscience

CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges

(2020) Simon Hornung et al.   Frontiers in Molecular Neuroscience

The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease

(2020) Simoneide S. Titze-de-Almeida et al.   Cells

Polydopamine Nanoparticles as an Organic and Biodegradable Multitasking Tool for Neuroprotection and Remote Neuronal Stimulation

(2020) Matteo Battaglini et al.   ACS Applied Materials & Interfaces

Down regulation of miR ‐218, miR ‐124, and miR ‐144 relates to Parkinson's disease via activating NF‐κB signaling

(2020) Rui‐Xian Xing et al.   KAOHSIUNG JOURNAL OF MEDICAL SCIENCES

Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era

(2020) Dunhui Li et al.   MEDICINAL RESEARCH REVIEWS

Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

(2020) Saba Naqvi et al.   Frontiers in Neuroscience

Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases

(2020) Yu Su et al.   Frontiers in Pharmacology

Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications

(2020) Marta Pajares et al.   Cells

Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders

(2020) Sujay Paul et al.   Cells

Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson’s disease patients

(2020) Yu Shu et al.   Open Life Sciences

Altered expression levels of microRNA-132 and Nurr1 in peripheral blood of Parkinson’s disease: a potential disease biomarker

(2019) Zhaofei Yang et al.   ACS Chemical Neuroscience

miR‐181a/b downregulation exerts a protective action on mitochondrial disease models

(2019) Alessia Indrieri et al.   EMBO Molecular Medicine

MicroRNAs: Game Changers in the Regulation of α-Synuclein in Parkinson’s Disease

(2019) Liang Zhao et al.   Parkinsons Disease

Dysfunction of Cellular Proteostasis in Parkinson’s Disease

(2019) Šárka Lehtonen et al.   Frontiers in Neuroscience

MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies

(2019) Gulcin Tezcan et al.   Frontiers in Pharmacology

The Potential for microRNA Therapeutics and Clinical Research

(2019) Johora Hanna et al.   Frontiers in Genetics

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

(2019) Nathan Kelley et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model

(2019) Qiang Sun et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology

(2019) David K. Simon et al.   CLINICS IN GERIATRIC MEDICINE

Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson’s disease model

(2019) Li Gan et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease

(2019) Yong-Bo Hu et al.   Cell Death & Disease

Levodopa treatment in Parkinson’s disease: earlier or later?

(2019) Federico Paolini Paoletti et al.   Annals of Translational Medicine

Intranasal delivery of targeted polyfunctional gold–iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide

(2019) Uday K. Sukumar et al.   BIOMATERIALS

Role of MicroRNAs in Parkinson’s Disease

(2019) Suh Yee Goh et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Biomarkers for Parkinson’s Disease: How Good Are They?

(2019) Tianbai Li et al.   Neuroscience Bulletin

MiR‐29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1

(2019) Ruili Wang et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Nanotechnology in cancer diagnosis: progress, challenges and opportunities

(2019) Ye Zhang et al.   Journal of Hematology & Oncology

Salivary microR‐153 and microR‐223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease

(2019) Marisa Cressatti et al.   MOVEMENT DISORDERS

The role of neutrophils in neuro-immune modulation

(2019) Alexandre Kanashiro et al.   PHARMACOLOGICAL RESEARCH

Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases

(2019) Chiara Martinelli et al.   Advanced Healthcare Materials

Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In Vivo

(2019) Meirav Segal et al.   Molecular Therapy-Nucleic Acids

The delta opioid peptide D-Alanine 2, Leucine 5 Enkephaline (DADLE)-induces neuroprotection through cross-talk between the UPR and pro-survival MAPK-NGF-Bcl2 signaling pathways via modulation of several micro-RNAs in SH-SY5Y cells subjected to ER stress

(2018) Erfath Thanjeem Begum Moghal et al.   CELL BIOLOGY INTERNATIONAL

Modulation in miR-200a/ SIRT1 axis is associated with apoptosis in MPP + -induced SH-SY5Y cells

(2018) Niloufar Salimian et al.   GENE

Epigenetic Regulation in Neurodegenerative Diseases

(2018) Amit Berson et al.   TRENDS IN NEUROSCIENCES

miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease

(2018) Marcia Cristina T. dos Santos et al.   Oncotarget

Linking Neuroinflammation and Neurodegeneration in Parkinson’s Disease

(2018) Géraldine Gelders et al.   Journal of Immunology Research

Recombinant Adeno-Associated Virus-Mediated Delivery of MicroRNA-21-3p Lowers Hypertension

(2018) Feng Wang et al.   Molecular Therapy-Nucleic Acids

Diagnostic Criteria for Parkinson’s Disease: From James Parkinson to the Concept of Prodromal Disease

(2018) Luca Marsili et al.   Frontiers in Neurology

Identification of Critical Genes and miRNAs Associated with the Development of Parkinson’s Disease

(2018) Jia Li et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease

(2018) Anna Elisa Roser et al.   Frontiers in Neuroscience

Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors

(2018) Fatemeh N. Emamzadeh et al.   Frontiers in Neuroscience

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation

(2018) Jacob O'Brien et al.   Frontiers in Endocrinology

MicroRNA-26a/Death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in Parkinson’s disease

(2018) Ying Su et al.   BIOLOGICAL PSYCHIATRY

microRNAs in Parkinson’s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches

(2017) Loredana Leggio et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson’s Disease

(2017) Christine Schwienbacher et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence

(2017) Jingwei Xue et al.   Nature Nanotechnology

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

(2017) Rajesha Rupaimoole et al.   NATURE REVIEWS DRUG DISCOVERY

Plasma levels of miR-137 and miR-124 are associated with Parkinson’s disease but not with Parkinson’s disease with depression

(2017) Na Li et al.   NEUROLOGICAL SCIENCES

MicroRNA biomarkers of Parkinson’s disease in serum exosome-like microvesicles

(2017) Xiang-Yang Cao et al.   NEUROSCIENCE LETTERS

MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3

(2017) Dongsheng Li et al.   Human Cell

miRNA-141 attenuates UV-induced oxidative stress via activating Keap1-Nrf2 signaling in human retinal pigment epithelium cells and retinal ganglion cells

(2017) Li-Bo Cheng et al.   Oncotarget

MicroRNAs in Parkinson’s disease

(2017) Abhishek Singh et al.   EXPERIMENTAL BRAIN RESEARCH

MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson’s Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways

(2017) Ying Liu et al.   MEDICAL SCIENCE MONITOR

BIM-mediated apoptosis and oncogene addiction

(2016) Yulin Li et al.   Aging-US

Serum miR-221 serves as a biomarker for Parkinson's disease

(2016) Wenbin Ma et al.   CELL BIOCHEMISTRY AND FUNCTION

Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer’s disease

(2016) Edward J. Goetzl et al.   FASEB JOURNAL

MicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression

(2016) Amrita Datta Chaudhuri et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease

(2016) C. Saraiva et al.   JOURNAL OF CONTROLLED RELEASE

Mitochondrial dysfunction in Parkinson's disease

(2016) Anindita Bose et al.   JOURNAL OF NEUROCHEMISTRY

Inflammatory Response in the CNS: Friend or Foe?

(2016) Marta Sochocka et al.   MOLECULAR NEUROBIOLOGY

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy

(2016) Tainá M. Marques et al.   MOLECULAR NEUROBIOLOGY

MiR-144-3p and Its Target Gene β-Amyloid Precursor Protein Regulate 1-Methyl-4-Phenyl-1,2-3,6-Tetrahydropyridine-Induced Mitochondrial Dysfunction

(2016) Kuo Li et al.   MOLECULES AND CELLS

Alterations of miRNAs reveal a dysregulated molecular regulatory network in Parkinson’s disease striatum

(2016) Venugopalan D. Nair et al.   NEUROSCIENCE LETTERS

Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease

(2016) Haixia Ding et al.   PARKINSONISM & RELATED DISORDERS

MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis

(2016) Min Cheng et al.   Oncotarget

MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian

(2016) Mingshu Mo et al.   Oncotarget

MicroRNA association with synucleinopathy conversion in rapid eye movement behavior disorder

(2015) Rubén Fernández-Santiago et al.   ANNALS OF NEUROLOGY

A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson’s disease

(2015) Hui Dong et al.   BIOMARKERS

MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson’s disease mouse

(2015) Zhao-Hui Wang et al.   BIOMEDICINE & PHARMACOTHERAPY

Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson’s disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway

(2015) Qinghua Ba et al.   BIOMEDICINE & PHARMACOTHERAPY

MiR-124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson's Disease by Targeting to Bim

(2015) Huiqing Wang et al.   BRAIN PATHOLOGY

Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons

(2015) Consiglia Pacelli et al.   CURRENT BIOLOGY

Parkinson’s disease and enhanced inflammatory response

(2015) Iva Stojkovska et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease

(2015) Dominik Haddad et al.   FEBS LETTERS

MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression

(2015) Savan Kabaria et al.   FREE RADICAL BIOLOGY AND MEDICINE

Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD

(2015) A. Serafin et al.   NEUROLOGY

Adeno-Associated Virus-Mediated MicroRNA Delivery and Therapeutics

(2015) Jun Xie et al.   SEMINARS IN LIVER DISEASE

Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease

(2015) YaXing Gui et al.   Oncotarget

Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization

(2014) Judith Eschbach et al.   ANNALS OF NEUROLOGY

Inhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease

(2014) Savan Kabaria et al.   FEBS LETTERS

 -Synuclein Is Localized to Mitochondria-Associated ER Membranes

(2014) C. Guardia-Laguarta et al.   JOURNAL OF NEUROSCIENCE

MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons

(2014) Woori Kim et al.   MOLECULAR NEUROBIOLOGY

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders

(2014) Margherita Grasso et al.   MOLECULES

Hydrogen peroxide responsive miR153 targets Nrf2/ARE cytoprotection in paraquat induced dopaminergic neurotoxicity

(2014) Madhusudhanan Narasimhan et al.   TOXICOLOGY LETTERS

Common features of microRNA target prediction tools

(2014) Sarah M. Peterson et al.   Frontiers in Genetics

MicroRNA-494 reduces DJ-1 expression and exacerbates neurodegeneration

(2013) Ran Xiong et al.   NEUROBIOLOGY OF AGING

Large  -synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking

(2013) B.-K. Choi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

 -Synuclein in Parkinson's Disease

(2013) L. Stefanis   Cold Spring Harbor Perspectives in Medicine

Comparison of Methods for miRNA Extraction from Plasma and Quantitative Recovery of RNA from Cerebrospinal Fluid

(2013) Melissa A. McAlexander et al.   Frontiers in Genetics

Circulating miRNAs: cell–cell communication function?

(2013) A. Turchinovich et al.   Frontiers in Genetics

Adult neurogenesis in Parkinson’s disease

(2012) Franz Marxreiter et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein

(2012) Hyun Jin Cho et al.   HUMAN MOLECULAR GENETICS

α-Synuclein Controls Mitochondrial Calcium Homeostasis by Enhancing Endoplasmic Reticulum-Mitochondria Interactions

(2012) Tito Calì et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1  Production

(2012) M. Haneklaus et al.   JOURNAL OF IMMUNOLOGY

Living on the edge with too many mouths to feed: Why dopamine neurons die

(2012) J. Paul Bolam et al.   MOVEMENT DISORDERS

MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship

(2012) Amy E. Pasquinelli   NATURE REVIEWS GENETICS

Magnetic Nanoparticles for Cancer Diagnosis and Therapy

(2012) Mehmet V. Yigit et al.   PHARMACEUTICAL RESEARCH

Identification of Novel microRNAs in Post-Transcriptional Control of Nrf2 Expression and Redox Homeostasis in Neuronal, SH-SY5Y Cells

(2012) Madhusudhanan Narasimhan et al.   PLoS One

Impaired neurotransmission caused by overexpression of  -synuclein in nigral dopamine neurons

(2012) M. Lundblad et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling

(2012) Kang Kang et al.   Journal of Animal Science and Biotechnology

A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA

(2011) Do Won Hwang et al.   BIOMATERIALS

MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism

(2011) Muhua Yang et al.   BREAST CANCER RESEARCH AND TREATMENT

The role of the precursor structure in the biogenesis of microRNA

(2011) Julia Starega-Roslan et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

A MicroRNA, mir133b, suppresses melanopsin expression mediated by failure dopaminergic amacrine cells in RCS rats

(2011) Yaochen Li et al.   CELLULAR SIGNALLING

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

(2011) Elena Miñones-Moyano et al.   HUMAN MOLECULAR GENETICS

The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response

(2011) Roberto Nicolete et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Several rAAV Vectors Efficiently Cross the Blood–brain Barrier and Transduce Neurons and Astrocytes in the Neonatal Mouse Central Nervous System

(2011) Hongwei Zhang et al.   MOLECULAR THERAPY

Etiology and pathogenesis of Parkinson's disease

(2011) Anthony H. Schapira et al.   MOVEMENT DISORDERS

Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153

(2010) Epaminondas Doxakis   JOURNAL OF BIOLOGICAL CHEMISTRY

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease

(2010) Ashley R. Winslow et al.   JOURNAL OF CELL BIOLOGY

Next Generation Sequencing of miRNAs – Strategies, Resources and Methods

(2010) Susanne Motameny et al.   Genes

Mitochondrial dynamics in Parkinson's disease

(2009) Victor S. Van Laar et al.   EXPERIMENTAL NEUROLOGY

Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons

(2009) Dong-Youn Hwang et al.   JOURNAL OF NEUROCHEMISTRY

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

(2009) Etienne C Hirsch et al.   LANCET NEUROLOGY